Funds holding APREA THERAPEUTICS INC
ISIN US03836J2015 · United States
- Fund holders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- 94.3K $
- Share of capital
- 0.8 % of 12.6M shares on Aug 12, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 71,125 | 65.2K $ | 0.00 % | 0.56 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 19,622 | 15K $ | 0.16 % | as of Mar 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 7,197 | 6.6K $ | 0.06 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 5,851 | 5.4K $ | 0.05 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 2,100 | 1.9K $ | 0.02 % | as of Feb 28, 2026 ↗ | |
| Diversified Equity Master Portfolio Master Investment Portfolio | 289 | 220.5 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 6 | 0 | 106,184 | +80.0 % |
| 2026Q1 | 6 | -1 | 58,981 | -69.1 % |
| 2025Q4 | 7 | -2 | 190,633 | -15.3 % |
| 2025Q3 | 9 | 0 | 225,187 | -0.7 % |
| 2025Q2 | 9 | -2 | 226,723 | -1.4 % |
| 2025Q1 | 11 | 0 | 230,051 | +2.7 % |
| 2024Q4 | 11 | -3 | 224,076 | +48.8 % |
| 2024Q3 | 14 | +2 | 150,599 | +7.4 % |
| 2024Q2 | 12 | +2 | 140,230 | +156.1 % |
| 2024Q1 | 10 | +1 | 54,759 | +6.0 % |
| 2023Q4 | 9 | 51,674 |
Institutional managers
20 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| AIGH Capital Management LLC | 1,015,541 | 774.8K $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 350,000 | 267K $ | as of Mar 31, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | 270,000 | 206K $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 205,760 | 157K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 119,131 | 90.9K $ | as of Mar 31, 2026 |
| Scientech Research LLC | 60,281 | 46K $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 39,817 | 30.4K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 25,100 | 19.1K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 22,330 | 17K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 21,052 | 16.1K $ | as of Mar 31, 2026 |
| HighTower Advisors, LLC | 13,864 | 10.6K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 13,500 | 10.3K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,018 | 9.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 8,504 | 6.5K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 5,127 | 3.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 2,153 | 1.6K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 577 | 440 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 295 | 225 $ | as of Mar 31, 2026 |
| WealthCollab, LLC | 158 | 121 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 16 | 12 $ | as of Mar 31, 2026 |
Declared shareholders of APREA THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vestal Point Capital, LP and 1 other | 9.90 % | 22,654,832 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding APREA THERAPEUTICS INC". https://titelia.com/en/stocks/aprea-therapeutics-inc-US03836J2015